Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PIERRE L DIONNE

Allopathic & Osteopathic Physicians Family Medicine

NPI
1861467789
CMS profile
311451
Location
HUDSON, NH

General Payments · PY2018–2024

$5,981.73

  • Reported across 339 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$299.70

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $299.70 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $84.24 2
Novo Nordisk AS $75.22 4
Boehringer Ingelheim Pharmaceuticals, Inc. $55.09 3
Lilly USA, LLC $23.62 1
Exact Sciences Corporation $21.99 1
ABBVIE INC. $21.56 1
TOLMAR, INC. $17.98 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,960.41 117
PY2019 $1,367.00 98
PY2020 $460.30 24
PY2021 $580.36 32
PY2022 $733.63 36
PY2023 $580.33 19
PY2024 $299.70 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.56 03/25/2024 Food and Beverage Undisputed 01/23/2026 1103644686 CMS
AstraZeneca Pharmaceuticals LP $66.36 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105587652 CMS
AstraZeneca Pharmaceuticals LP $17.88 02/16/2024 Food and Beverage Undisputed 01/23/2026 1105305346 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.32 02/09/2024 Food and Beverage Undisputed 01/23/2026 1118192944 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.74 05/31/2024 Food and Beverage Undisputed 01/23/2026 1118192936 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.03 06/14/2024 Food and Beverage Undisputed 01/23/2026 1118192940 CMS
Exact Sciences Corporation $21.99 12/06/2024 Food and Beverage Undisputed 01/23/2026 1114637901 CMS
Lilly USA, LLC $23.62 02/23/2024 Food and Beverage Undisputed 01/23/2026 1135296644 CMS
Novo Nordisk Inc $21.77 01/05/2024 Food and Beverage Undisputed 01/23/2026 1096675835 CMS
Novo Nordisk Inc $21.72 03/08/2024 Food and Beverage Undisputed 01/23/2026 1097491171 CMS
Novo Nordisk Inc $14.50 07/30/2024 Food and Beverage Undisputed 01/23/2026 1096823596 CMS
Novo Nordisk Inc $17.23 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097275975 CMS
Tolmar, Inc. $17.98 07/06/2024 Food and Beverage Undisputed 01/23/2026 1138714494 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.